Table 3.
Baseline Characteristics of Patients With Virological Failure
| Patients With VF | RAM (Frequency) | Resistance Using ANRS Algorithm | Resistance Using Stanford Algorithm |
|---|---|---|---|
| Patients 1–7 | None | None | None |
| Patient 8 | 138A (99.9%) | Rilpivirine | Rilpivirine |
| Patient 9 | 106I (99.2%) | None | None |
| Patient 10 | 106I (98.6%) | None | None |
| Patient 11 | 98S (97.9%) | Nevirapine | None |
| Patient 12 | 98G (90.7%) | None | Rilpivirine |
| Patient 13 | 179I (17.4%) | None | None |
| Patient 14 | 65N (1.3%) | Tenofovir | Tenofovir |
| Patient 15 | 90I (1.1%) | None | None |
Abbreviations: ANRS, French National Agency for Research on AIDS and Viral Hepatitis; RAM, resistance-associated mutation; VF, virological failure.